Fresenius Kabi חוגג את הרחבת הפארמה $100M, ומביא 445 משרות חדשות לווילסון

פרזניוס קאבי, a global health care company based in Germany, hosted a topping off ceremony last week to celebrate the $100 million expansion of its pharmaceutical manufacturing campus in ווילסון.

The topping off ceremony was a traditional celebration of construction projects upon the installation of the topmost structural member – in this case, signing celebrants’ names on the final huge steel I-beam at the growing pharmaceutical production center in Wilson.

ההרחבה תוסיף לפחות 445 משרות חדשות לכוח העבודה של 100 פלוס ב- מחוז ווילסון אתר עד למועד השלמתו בשנת 2022, והגדיל את הייצור של החברה של תרופות גנריות זולות לשימוש בבתי חולים ומרפאות.

The North Carolina Biotechology Center provided technical support for the corporate expansion, in partnership with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. Other partners included the North Carolina General Assembly, the North Carolina Community College System, Wilson County, the City of Wilson, and the Wilson Economic Development Council.

Fresenius Kabi, with global headquarters in Bad Homburg, Germany, specializes in medicines and technologies for infusion, transfusion and clinical nutrition used to help critically and chronically ill patients.

The company broke ground in September 2017 on a $250 million expansion at its pharmaceutical manufacturing site in Melrose Park, Ill. In total, the company employs more than 3,000 people in the U.S., including at its U.S. headquarters in Lake Zurich, Ill.

מקור המאמר: WRAL Techwire

למידע נוסף על מחוז וילסון